Atinary is thrilled to announce the strategic collaboration with Takeda, the largest Japanese pharmaceutical company, to drive innovation in healthcare.
This partnership brings together their complementary expertise, paving the way for innovative AI solutions poised to transform pharmaceutical R&D and accelerate drug discovery. Through this collaboration, Takeda will leverage Atinary’s leading AI Self-Driving Labs technology, that combined with its expertise in R&D and drug discovery aim to create a more robust and efficient drug development process, ultimately benefiting patients worldwide.
